Tools
Tools
Eichmann, Xuemei (2020) Exploring Patient Engagement in Pharmaceutical Medicine Development: A Value Creation Perspective. PhD thesis, University of Gloucestershire. doi:10.46289/ME66RS16
|
Text (Final thesis)
10709 Eichmann (2020) Exploring patient engagement in pharmaceutical medicine development - a value creation perspective.pdf - Accepted Version Available under License All Rights Reserved. Download (5MB) | Preview |
Abstract
Patient engagement (PE) has rapidly expanded in medicine development in recent years. Despite the volume of literature on this concept, there has been little conceptualization of this new phenomenon, which is still ambiguous and fragmented. A clear understanding of PE in medicine development from a value-creation perspective is much advocated, yet sparsely studied in the literature. Taking a social constructivist stance, this study found PE in medicine development as a multi-dimensional and multi-level complex social phenomenon. Therefore, a holistic account of PE in medicine development from the perspectives of key stakeholders (i.e., patient, society, and PHARMA) was developed to answer the what and how questions regarding PE in medicine development from a value-creation perspective. This study explored the concept of PE in medicine development through identifying the antecedents, attributes, consequences and influencing factors of PE in medicine development, employing Rodgers’ (1989) concept development approach. Thereby, a thematic analysis of interviews with key stakeholders (i.e., patients, medicine developers, and PE experts) and literature provided the following PE definition in medicine development: Patient engagement in medicine development means co-creation of value for patients, healthcare and all healthcare stakeholders through partnership and collaboration between healthcare actors and patients along the medicine development lifecycle, to allow integration of patient value in medicine development by engaging the patients as value co-creators of health outcomes. This study revealed that PE in medicine development requires alignment among healthcare stakeholders on value perspectives based on patient value. Thereby, co-creation was found as a core attribute, while patient centricity a core antecedent and improved value a core consequence of PE in medicine development. The PE conceptual framework and theoretical propositions developed in this study offer a conceptualization of PE in medicine development, providing foundational work and practical guidance to healthcare actors to further advance this concept in theory and practice.
| Item Type: | Thesis (PhD) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thesis Advisors: |
|
|||||||||
| Uncontrolled Keywords: | Medicines development; Patient engagement | |||||||||
| Subjects: | R Medicine > RS Pharmacy and materia medica | |||||||||
| Divisions: | Schools and Research Institutes > School for Health | |||||||||
| Depositing User: | Susan Turner | |||||||||
| Date Deposited: | 17 Feb 2022 11:21 | |||||||||
| Last Modified: | 30 Nov 2022 16:58 | |||||||||
| URI: | https://eprints.glos.ac.uk/id/eprint/10709 |
University Staff: Request a correction | Repository Editors: Update this record
